The activation of PPARγ by 15d-PGJ2 has also been demonstrated to inhibit tyrosine phosphorylation of epidermal growth factor receptors ErbB-2 and ErbB-3 in a breast cancer cell line, leading to a dramatic increase in apoptosis [159]. Here, EGFR is linked to breast carcinoma.